High-precision automated systems designed for Tokyo and Osaka clinical laboratory standards.
Japan stands as a global hub for medical innovation, driven by an aging population and a healthcare system that demands unparalleled precision. As a premier Blood Analysis Systems Manufacturer & Factory, our integration into the Japanese market focuses on the "Society 5.0" vision—where AI and automation solve complex diagnostic challenges.
In Japanese clinical settings, from the university hospitals in Nagoya to community clinics in Hokkaido, the transition toward In-Vitro Diagnostics (IVD) automation is accelerating. Our systems are engineered to meet the stringent Pharmaceuticals and Medical Devices Agency (PMDA) expectations, ensuring every hematology report and blood culture result contributes to life-saving decisions.
Integration of machine learning algorithms in blood analysis allows for earlier detection of septicemia and rare hematological disorders, reducing the workload of Japanese lab technicians.
Point-of-Care Testing (POCT) systems are becoming essential in Japan's rural areas, providing instant blood gas and chemistry analysis without the need for central lab transport.
Japanese hospitals are increasingly selecting manufacturers with green policies. Our factory focuses on reducing reagent waste and energy-efficient hardware design.
Ningbo Medvok Medical Co., Ltd. is a high-tech biotechnology company focused on the R&D and production of antigens, antibodies and downstream detection reagents for diagnosis and therapy. Our product pipelines cover cardiovascular and cerebrovascular, inflammation, infectious diseases, tumors, hormones and other categories, from raw materials to finished products.
Innovation is in our DNA! Our products have been delivered to more than 60 countries, including key partnerships within the Japanese industrial sector. Using the ISO 13485 management system, our product quality is greatly trusted by Japanese medical institutions and global distributors alike.
Implementation of high-throughput 64-position bacteria analyzers to handle the massive patient inflow, ensuring rapid identification of blood pathogens in metropolitan clinical centers.
Deployment of portable blood gas and chemistry systems for rapid diagnostics, facilitating the Japanese "aging in place" healthcare model for home-care patients.
Utilizing Peltier Thermal Cyclers and Real-Time PCR systems for genomic blood analysis, supporting Japan's leading research in oncology and personalized medicine.
As an IVD solutions provider, we have worked and will keep working intensively to support research and foment knowledge and prevention of diseases. For us, a well-informed society is a healthier society. We care about protecting human health and hope all of society, especially in the demanding Japanese market, to have access to clean, affordable, and reliable biotechnologies.
Furthermore, our economic development will be compatible with proper conduct in relation to ethics, society, the workplace, the environment and respect for human rights. We think of society as a group of individuals with equal rights and opportunities. In order to materialize this commitment, we have developed a sustainability policy on environmental and social matters that aligns with Japanese ESG standards.
Explore our full range of Japanese-market-optimized diagnostic equipment.
Medvok Medical
